Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000921895-25-001848·AYTU BIOPHARMA, INC
Schedule 13G ownership disclosure
Aytu BioPharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 054754858
Event date: 2025-05-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Philotimo Fund, LP
Shares: 111,400.00 · Class: 1.8%
- Philotimo Focused Growth & Income Fund
Shares: 54,868.00 · Class: 0.9%
- Kanen Wealth Management LLC
Shares: 166,268.00 · Class: 2.7%
- Kanen David
Shares: 166,268.00 · Class: 2.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-001848
- Form type
- SCHEDULE 13G/A
- Filer
- AYTU BIOPHARMA, INC
- CIK
- CIK 1385818
- Filed
- Jun 26, 2025
- Reporting period
- May 22, 2025
- Description
- Schedule 13G beneficial ownership